stabilized HER-2 peptide ligands (Lanthio)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestabilized HER-2 peptide ligands (Lanthio)
Drug Alias NameHER-2 peptide ligands targeting HER-2
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLanthio Pharma Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLanthio Pharma Bv
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A